Implications of the new FDA/CDER immunotoxicology guidance for drugs (Q34998153)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Implications of the new FDA/CDER immunotoxicology guidance for drugs |
scientific article |
Statements
1 reference
Implications of the new FDA/CDER immunotoxicology guidance for drugs (English)
1 reference
Kenneth L Hastings
1 reference
Center for Drug Evaluation and Research, US Food and Drug Administration
1 reference
1 October 2002
1 reference
1 reference
2
1 reference
11
1 reference
1613-1618
1 reference
Identifiers
1 reference
1 reference